Towa Yakuhin KK

4553

Equity

ISIN JP3623150004 / Valor 248084

Tokyo Stock Exchange (2024-11-19)

JPY 2,818.00-1.26%

Towa Yakuhin KK
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Towa Yakuhin KK is a Japanese pharmaceutical company specializing in the development, manufacturing, and distribution of generic drugs.

Summarized from source with an LLMView SourceSector: Healthcare

Net Sales

Towa Yakuhin KK reported net sales of 227,934 million yen for the fiscal year ending March 31, 2024. This represents an increase from the previous fiscal year's net sales of 208,859 million yen.

Operating Profit

For the fiscal year ending March 31, 2024, Towa Yakuhin KK achieved an operating profit of 17,647 million yen. This is a significant improvement compared to the 5,514 million yen recorded in the previous fiscal year.

Ordinary Profit

Towa Yakuhin KK's ordinary profit for the fiscal year ending March 31, 2024, was 24,477 million yen. This marks a substantial increase from the 5,141 million yen reported in the prior fiscal year.

Profit Attributable to Owners

The profit attributable to owners of Towa Yakuhin KK for the fiscal year ending March 31, 2024, was 16,173 million yen. This is a notable rise from the 2,201 million yen reported in the previous fiscal year.

Earnings Per Share

Towa Yakuhin KK reported earnings per share of 328.59 yen for the fiscal year ending March 31, 2024. This is a significant increase from the 44.72 yen per share reported in the previous fiscal year.

Summarized from source with an LLMView Source

Key figures

13.3%1Y

2.32%3Y

2.40%5Y

Performance

34.3%1Y

31.7%3Y

30.5%5Y

Volatility